“…However, the drug industry, which has been facing several waves of technological discontinuities, does not seem to be following that path when technological discontinuities occur (Allarakhia and Walsh, 2011;Galambos and Sturchio, 1998;Hopkins, Martin et al, 2007;Rothaermel, 2000), which questions the notion of drivers of evolution in technology based industries. But when technological discontinuity does not lead to disruptions of its dominant logic, what other forces lead to such change?…”